52
Participants
Start Date
May 31, 2015
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
514G3 (2 mg/kg) plus standard IV antibiotic treatment
True Human Monoclonal Antibody
514G3 (10 mg/kg) plus standard IV antibiotic treatment
True Human Monoclonal Antibody
514G3 (40 mg/kg) plus standard IV antibiotic treatment
True Human Monoclonal Antibody
Placebo plus standard IV antibiotic treatment
Sterile isotonic formulation buffered at pH 6.2 - 6.5 plus standard IV antibiotic treatment
514G3 (40 mg/kg) plus standard IV antibiotic treatment: Phase II
A single dose of 514G3 plus standard IV antibiotic therapy
Placebo plus standard IV antibiotic treatment: Phase II
A single dose of placebo plus standard IV antibiotic therapy
XBiotech Investigative Site, Charlotte
XBiotech Investigative Site, Columbus
XBiotech, Inc.
INDUSTRY